FDA Panel Backs Wider Use of Drug to Treat Early Stage Breast Cancer
Perjeta, which seems to shrink early stage tumors, might gain quick FDA approvalContinue Reading
Perjeta, which seems to shrink early stage tumors, might gain quick FDA approvalContinue Reading
Bacteria involved in cavity formation may have some cancer-protective effect, researcher says, but skeptics aren’t sure
Continue Reading
Bacteria involved in cavity formation may have some cancer-protective effect, researcher says, but skeptics aren’t sure
Continue Reading
Finding might offer doctors a ‘practical tool,’ researcher suggestsContinue Reading
Seven tumor-specific genes appear to yield accurate prognosis, study saysContinue Reading
Finding might one day improve rates of overtreatment, undertreatment in men, study saysContinue Reading
Rising costs, complexity of cases and aging population portend trouble, experts warnContinue Reading
Rising costs, complexity of cases and aging population portend trouble, experts warnContinue Reading
Perjeta might gain quick FDA approvalContinue Reading
At some hospitals 1 in 4 patients returns for emergency care following colon operationContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.